![](/img/cover-not-exists.png)
A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO)
Sehouli, Jalid, Tomè, Oliver, Dimitrova, Desislava, Camara, Oumar, Runnebaum, Ingo Bernhard, Tessen, Hans Werner, Rautenberg, Beate, Chekerov, Radoslav, Muallem, Mustafa Zelal, Lux, Michael Patrick, TVolume:
143
Language:
english
Journal:
Journal of Cancer Research and Clinical Oncology
DOI:
10.1007/s00432-016-2307-0
Date:
March, 2017
File:
PDF, 1.32 MB
english, 2017